期刊文献+

肝硬化患者血浆及胃粘膜内血管活性肠肽和生长抑素含量的变化及意义 被引量:1

CHANGE OF VASOACTIVE INTESTINAL PEPTIDE AND SOMATOSTATIN CONTENTS IN PLASMA AND GASTEIC MUCOSA AND THEIR SIGNIFICANCE IN PATIENTS WITH HEPATIC CIRRHOSIS
原文传递
导出
摘要 采用放射免疫测定法研究了肝硬化(HC)患者血浆及胃粘膜内血管活性肠肽(VIP)和生长抑素(SS)含量变化及其意义。结果表明:肝硬化患者血浆和胃粘膜内的VIP含量和SS含量均显著高于正常对照组(P<0.01);HC伴溃疡病患者血浆及胃粘膜中SS含量显著高于无溃疡的HC患者(P<0.05);血浆及胃粘膜中VIP的含量随着胃、十二指肠粘膜充血程度的加剧而升高;并且血浆及胃粘膜内VIP和SS含量与肝功能密切相关。提示:在HC时存在着严重的胃肠激素代谢率乱,并且它在HC的病理生理机制和HC时胃肠功能改变和病理变化中起着重要作用。 The contents of vasoactive intestinal peptide(VIP) and somatostatin(SS) in palsma and gastric mucosa in patients with hepatic cirrhosis(HC) were tested by redioimmunoassay. The results showed that the contents of VIP and SS in patients with HC were significantly higher than in normal subjects(P<0.01);the contents of SS in cases of HC with peptic ulcer were sinificantly higher than that without peptic ulcer(P<0.05).A positive correlation was noted between contents of VIP and the degree of con- gestion of gastroduodeual mucosa(P<0.05) and esophageal varices(P<0.05).There was a negative corre-lation between contents of VIP,SS and albnmin(P<0.01)and a positive correlation between contents of VIP,SS and prothrombin time(P<0.01),The results suggest that there was severe disorder of gastrointestinal hormones in patients with HC.
出处 《肝脏病杂志》 CSCD 1995年第3期152-154,共3页
关键词 肝硬化 血管活性肠肽 生长抑素 胃疾病 并发症 Hepatic cirrhosis Vasoactive intestial paptide Somatostatin
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部